Julie Hill

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.2K citations · Full text

Surgical Oncology, Chemotherapy Versus Chemotherapy, Gastrointestinal Oncology +8

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Eric Van Cutsem, Yung‐Jue Bang, Feng-yi Feng et al. · Gastric Cancer · 2014 · 588 citations · Full text

Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)

Eric Van Cutsem, Yoon‐Koo Kang, Hyun Cheol Chung et al. · Journal of Clinical Oncology · 2009 · 204 citations

Advanced Gastric Cancer, Cancer Management, Pathology +16

Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)

Eric Van Cutsem, Yoon‐Koo Kang, Hyun Chul Chung et al. · Journal of Clinical Oncology · 2009 · 90 citations

Breast Oncology, Advanced Gc, Advanced Gastric Cancer +17

Tolerability of Beta-Blockers in Elderly Patients with Chronic Heart Failure: The COLA II Study

Henry Krum, Julie Hill, Friedrich Fruhwald et al. · European Journal of Heart Failure · 2005 · 75 citations · Full text